Novavax (NVAX) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $9.32 -0.32%
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
EPAC, SAR, KRUS, More
EPS Growth %: -164.5%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.08), $0.01 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $8.2 million versus the consensus estimate of $9.2 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- RenaissanceRe Holdings (RNR) PT Raised to $315 at TD Cowen
- TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
